Honokiol Ameliorates Cerebral Infarction from Ischemia-Reperfusion Injury in Rats

Abstract

Honokiol, a constituent extracted from Magnolia officinalis, had been shown be an antioxidant and an anti-platelet agent in biological systems with an anti-arrhythmic effect and a myocardial protective effect on ischemia-reperfusion injury. We examined the neuroprotective effect of honokiol in rats subjected to focal cerebral ischemia. Honokiol was administered intravenously either at fifteen minutes before right middle cerebral artery occlusion (pretreatment groups) or when both common carotid arteries clips were removed (treatment groups). The results showed that there was no significant hemodynamic change after intravenous infusion of honokiol at the dosages of 10 ^{- 8}, 10 ^{- 7} and 10 ^{- 6} g/kg in both groups. However, honokiol significantly reduced the total volume of infarction at the doses of 10 ^{- 7} or 10 ^{- 6} g/kg in both pretreatment and treatment groups. This study suggests that honokiol is a potent neuroprotective agent in focal cerebral ischemia. This beneficial effect may be related to its antioxidant effect and anti-platelet aggregation activity.

Key words

Honokiol - antioxidant - free radical - ischemia - reperfusion - cerebral infarction - Magnolia officinalis - Magnoliaceae

References

• 1 Taira J, Ikemoto T, Miruma K, Hagi A, Murakami A, Makino K. Effective inhibition of hydroxyl radicals by hydroxylated biphenyl compounds.  Free Radic Res Commun. 1993;  19 S71-7
• 2 Teng C M, Chen C C, Ko F N, Lee L G, Huang T F, Chen Y P. et al . Two antiplatelet agents from Magnolia officinalis .  Thromb Res. 1988;  50 757-65
• 3 Lo Y C, Teng C M, Chen C F, Chen C C, Hong C Y. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation.  Biochem Pharmacol. 1994;  47 549-53
• 4 Chiu J H, Ho C T, Wei Y H, Liu W Y, Hong C Y. In vitro and in vivo protective effect of honokiol on rat liver from lipid peroxidative injury.  Life Sci. 1997;  61 1967-71
• 5 Tsai S K, Huang S S, Hong C Y. Myocardial protective effect of honokiol: an active component in Magnolia officinalis .  Planta Med. 1996;  62 503-6
• 6 Tsai S K, Hong C Y, Huang S S, Hung L M, Hong C Y. Antiarrhythmic effect of magnolol and honokiol during acute phase of coronary occlusion in anesthetized rats: influence of L-NAME and aspirin.  Pharmacology. 1999;  59 227-33
• 7 Son H J, Lee H J, Yun-Choi H S, Ryu J H. Inhibitors of nitric oxide synthesis and TNF-alpha expression from Magnolia obovata in activated macrophages.  Planta Med. 2000;  66 469-71
• 8 Hall E D, Braughler J M. Central nervous system trauma and stroke, II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation.  Free Radic Biol Med. 1989;  6 303-13
• 9 Flamm E S, Demopoulos H B, Seligman M l, Poser G R, Ransohoff J. Free radicals in cerebral ischemia.  Stroke. 1978;  9 445-7
• 10 Kitagawa K, Matsumoto M, Oda T, Niinobe M, Hata R, Handa N. et al . Free radical generation during brief period of cerebral ischemia may trigger delayed neuronal death.  Neuroscience. 1990;  35 551-8
• 11 Huang S S, Tsai M C, Chih C L, Hung L M, Tsai S K. Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia.  Life Sci. 2001;  69 1057-65
• 12 Isayama K, Pitts L H, Nishimura M C. Evaluation of 2,3,5-triphenyltetrazolium chloride staining to delineate rat brain infarcts.  Stroke. 1991;  22 1394-8
• 13 Chen S T, Hsu C Y, Hogan E L, Marico H, Balentine J D. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction.  Stroke. 1986;  17 738-43
• 14 Coyle P. Middle cerebral artery occlusion in the young rat.  Stroke. 1982;  13 855-9
• 15 Garcia J H. Experimental ischemic stroke: a review.  Stroke. 1984;  15 5-14
• 16 Mendelow A D, Graham D I, Mc Culloch J, Mohaned A. The distribution of ischemic damage and cerebral blood flow after unilateral carotid occlusion and hypotension in the rat.  Stroke. 1984;  15 704-10